Results 131 to 140 of about 12,672,734 (314)

Assessment of the Quality of Smartphone-Based Applications and Games for Teaching Medical Terminology Using the Mobile Application Rating Scale (MARS) [PDF]

پیاورد سلامت
Background and Aim: Proficiency in medical terminology is a basic competency of most medical students, which ensures communication with other healthcare providers.
Seyyedeh Fatemeh Mousavi Baigi, Reyhaneh Norouzi Aval, Masoumeh Sarbaz, Khalil Kimiafar   +3 more
doaj  

vexptoolbox: A software toolbox for human behavior studies using the Vizard virtual reality platform [PDF]

, 2022
Immo Schuetz, Harun Karimpur, Katja Fiehler   +2 more
openalex   +1 more source

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

Molecular Oncology, EarlyView.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande, Marcela de Oliveira Silva, Mariana Bisarro dos Reis, Rodrigo de Oliveira Cavagna, Luciane Sussuchi, Icaro Alves Pinto, Natalia Zampieri Pontes, Rodrigo Sampaio Chiarantano, Flavio Augusto Ferreira da Silva, Pedro de Marchi, Letícia Ferro Leal, Rui M. Reis   +11 more
wiley   +1 more source

The NifTK software platform for image-guided interventions: platform overview and NiftyLink messaging [PDF]

, 2014
Matthew J. Clarkson, Gergely Zombori, Stephen Thompson, Johannes Totz, Yi Song, Miklos Espak, Stian Johnsen, David J. Hawkes, Sébastien Ourselin   +8 more
openalex   +1 more source

Aggressive prostate cancer is associated with pericyte dysfunction

Molecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero, Ane Martinez‐Larrinaga, Joaquim Grego‐Bessa, Saioa Garcia‐Longarte, Hielke van Splunder, Ianire Astobiza, Amaia Ercilla, Laura Bozal‐Basterra, Isabel Mendizabal, Pilar Villacampa, Arkaitz Carracedo, Mariona Graupera   +11 more
wiley   +1 more source

Towards FAIR principles for research software

, 2019
Anna‐Lena Lamprecht, Leyla García, Mateusz Kuzak, Carlos Martínez-Ortiz, Ricardo Arcila, Eva Martín del Pico, Victoria Domínguez Del Angel, Stephanie van de Sandt, Jon Ison, Paula Andrea Martinez, Peter McQuilton, Alfonso Valencia, Jennifer Harrow, Fotis Psomopoulos, Josep Lluis Gelpí, Neil Chue Hong, Carole Goble, Salvador Capella-Gutiérrez   +17 more
openalex   +2 more sources

MSP-Tool: A VBA-Based Software Tool for the Analysis of Multispecimen Paleointensity Data [PDF]

, 2015
M. Monster, Lennart V. de Groot, Mark J. Dekkers   +2 more
openalex   +1 more source

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

Molecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang, Qian Sun, Daniel Novak, Lei Zhu, Juliane Poelchen, Tamara Steinfass, Yiman Wang, Viktor Umansky, Jochen Utikal   +8 more
wiley   +1 more source

NeuroMatic: An Integrated Open-Source Software Toolkit for Acquisition, Analysis and Simulation of Electrophysiological Data

, 2018
Jason S. Rothman, R. Angus Silver
openalex   +1 more source

Plasma extrachromosomal circular DNA as a biomarker in EGFR‐targeted therapy of non‐small cell lung cancer

Molecular Oncology, EarlyView.
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard, Sarmad Mehmood, Eva Boysen Fynboe Ebert, Peter Meldgaard, Anindya Dutta, Boe S. Sorensen   +5 more
wiley   +1 more source